MYX to present at Citizens JMP Life Sciences Conference
Released
Released
Announcement PDF
ASX Announcement
MAYNE PHARMA TO PRESENT AT CITIZENS JMP LIFE
SCIENCES CONFERENCE
29 April 2024, Adelaide, Australia: Mayne Pharma Group Limited (ASX: MYX) today announced that
Shawn Patrick O’Brien, Chief Executive Officer, and Aaron Gray, Chief Financial Officer of Mayne
Pharma, will present at the Citizens JMP Life Sciences Conference in New York City as follows:
Date:
Time:
Webcast:
Monday, 13 May 2024
2:00pm EDT (Tuesday, 14 May 2024 at 4.00am AEST)
Click Here
To schedule a 1x1 meeting with the Company, please contact your Citizens JMP institutional sales
representative.
The live and archived webcast of the presentation will be accessible from the Company’s website
www.maynepharma.com under Investor Relations. The replay of the webcast will be accessible for
90 days.
For further information contact:
Australia:
Craig Haskins
+61 421 029 843
ir@maynepharma.com
USA:
Lisa M. Wilson
+1 917-543-9932
ir@maynepharma.com
Authorised for release to the ASX by the Chair
About Mayne Pharma
Mayne Pharma is an ASX-listed specialty pharmaceutical company focused on commercialising
novel pharmaceuticals, offering patients better, safe and more accessible medicines. Mayne
Pharma also provides contract development and manufacturing services to clients worldwide.
Mayne Pharma has a 40year track record of innovation and success in developing new oral drug
delivery systems. These technologies have been successfully commercialised in numerous products
that continue to be marketed around the world. To learn more about Mayne Pharma, please visit
maynepharma.com.
Share your feedback
Discover